Basic Information
| LncRNA/CircRNA Name | ANRIL |
| Synonyms | NA |
| Region | GRCh38_9:21994778-22121097 |
| Ensemble | ENSG00000240498 |
| Refseq | NR_003529 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | pancreatic cancer |
| ICD-0-3 | C25 |
| Methods | Luciferase, etc. |
| Sample | PC cell lines Panc-1 and SW1990 |
| Expression Pattern | differentially expressed |
| Function Description | rs1537373 in ANRIL may influence transcription factor binding and regulate CDKN2B expression, thus confer the susceptibility to PC. |
| Pubmed ID | 30604909 |
| Year | 2019 |
| Title | A functional variant rs1537373 in 9p21.3 region is associated with pancreatic cancer risk. |
External Links
| Links for ANRIL | GenBank HGNC NONCODE |
| Links for pancreatic cancer | OMIM COSMIC |